Santhera Pharmaceuticals Holding AG Logo

Santhera Pharmaceuticals Holding AG

SANN | SW

Overview

Corporate Details

ISIN(s):
CH1276028821
LEI:
54930035HAOFTTQH0U85
Country:
Switzerland
Address:
HOHENRAINSTRASSE 24, 4133 PRATTELN
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Santhera Pharmaceuticals Holding AG is a specialty pharmaceutical company focused on the development and commercialization of innovative medicines for rare diseases with high unmet medical need. The company's core therapeutic areas of focus are neuromuscular and pulmonary disorders. Its clinical pipeline includes drug candidates for conditions such as Duchenne muscular dystrophy (DMD) and involves the development of advanced treatments like gene therapy for specific congenital muscular dystrophies.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Santhera Pharmaceuticals Holding AG. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Santhera Pharmaceuticals Holding AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Santhera Pharmaceuticals Holding AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2022-01-11 N/A Non-Executive member Buy None 42,600.00 CHF
2022-01-10 N/A Executive member Buy None 14,420.00 CHF
2022-01-05 N/A Executive member Buy None 37,000.00 CHF

Peer Companies

Company Country Ticker View
Univo Pharmaceuticals Ltd. Logo
Vertically integrated biopharma firm developing medical cannabis treatments with a focus on CNS.
Israel UNVO-M
Valbiotis Logo
Develops clinically tested, plant-based supplements for metabolic & cardiovascular health.
France ALVAL
Valneva SE Logo
Specialty vaccine developer for travelers and infectious diseases like chikungunya.
France VLA
VENTURE LIFE GROUP PLC Logo
Develops and distributes consumer self-care products for the ageing population worldwide.
United Kingdom VLG
Vetoquinol SA Logo
Develops and distributes veterinary drugs and products for livestock and companion animals globally.
France VETO
Vifor Pharma AG Logo
Develops iron-based pharmaceuticals for iron deficiency, nephrology, and rare diseases.
Switzerland VIFN
Virbac Logo
A pharmaceutical company developing animal health solutions for vets, farmers, and pet owners worldwide.
France FR000
ViroGates A/S Logo
Develops suPAR diagnostic tests for inflammation risk assessment in acute care and longevity.
Denmark VIRO
Vistin Pharma Logo
A leading global producer of Metformin API for the international pharmaceutical industry.
Norway VISTN
Vita 34 AG Logo
A cell bank storing umbilical cord stem cells as biological insurance for families' future health.
Germany V3V